BR0314716A - Anticorpos de subunidade alfa de lfa-1 e métodos de uso - Google Patents

Anticorpos de subunidade alfa de lfa-1 e métodos de uso

Info

Publication number
BR0314716A
BR0314716A BR0314716-9A BR0314716A BR0314716A BR 0314716 A BR0314716 A BR 0314716A BR 0314716 A BR0314716 A BR 0314716A BR 0314716 A BR0314716 A BR 0314716A
Authority
BR
Brazil
Prior art keywords
lfa
alpha subunit
methods
subunit antibodies
antibodies
Prior art date
Application number
BR0314716-9A
Other languages
English (en)
Inventor
Pamela M Kapustay
Rex H Lewis
Original Assignee
Aids Res Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32029897&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0314716(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aids Res Llc filed Critical Aids Res Llc
Publication of BR0314716A publication Critical patent/BR0314716A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Abstract

"ANTICORPOS DE SUBUNIDADE ALFA de LFA-1 E MéTODOS DE USO". São fornecidos anticorpos úteis para tratar condições fisiológicas e doenças associadas com a subunidade alfa de LFA-1, doenças essas tratáveis com um anticorpo que se liga à subunidade alfa de LFA-1, tal como HIV, e métodos para tratar essas doenças.
BR0314716-9A 2002-09-27 2003-09-25 Anticorpos de subunidade alfa de lfa-1 e métodos de uso BR0314716A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/261,164 US6919077B2 (en) 2002-09-27 2002-09-27 LFA-1 alpha subunit antibodies and methods of use
PCT/US2003/030529 WO2004029214A2 (en) 2002-09-27 2003-09-25 Lfa-1 alpha subunit antibodies and methods of use

Publications (1)

Publication Number Publication Date
BR0314716A true BR0314716A (pt) 2005-07-26

Family

ID=32029897

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314716-9A BR0314716A (pt) 2002-09-27 2003-09-25 Anticorpos de subunidade alfa de lfa-1 e métodos de uso

Country Status (9)

Country Link
US (3) US6919077B2 (pt)
EP (1) EP1545601A4 (pt)
JP (1) JP2006501283A (pt)
CN (1) CN1703240A (pt)
AU (1) AU2003277003A1 (pt)
BR (1) BR0314716A (pt)
CA (1) CA2499924A1 (pt)
WO (1) WO2004029214A2 (pt)
ZA (1) ZA200503173B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006304382A1 (en) * 2005-10-14 2007-04-26 The Johns Hopkins School Of Medicine Reduction and prevention of cell-associated HIV transepithelial migration, microbides and other formulations and methods
US8021668B2 (en) * 2005-12-12 2011-09-20 Immune Disease Institute, Inc. Integrin alpha L I domain mutants with increased binding affinity
EP3187585A1 (en) 2010-03-25 2017-07-05 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
PL2691530T3 (pl) 2011-06-10 2019-02-28 Oregon Health & Science University Glikoproteiny i rekombinowane wektory CMV
US20140140997A1 (en) * 2011-06-17 2014-05-22 Cytodyn Inc. Methods of Treating Retroviral Infections in Felines
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US20150079075A1 (en) * 2011-09-15 2015-03-19 Cytodyn Inc. Anti-CD11A Antibodies and Uses Thereof
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
CA2944989A1 (en) * 2013-04-08 2014-10-16 Cytodyn Inc. Felinized antibodies and methods of treating retroviral infections in felines
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002869A (en) * 1987-11-02 1991-03-26 Dana-Farber Cancer Institute Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes
JP3976333B2 (ja) * 1992-09-16 2007-09-19 ザ スクリップス リサーチ インスティチュート 呼吸合胞体ウイルスに対するヒト中和性モノクローナル抗体
DK1438970T3 (da) * 1993-03-19 2008-12-15 D Allen Allen Fremgangsmåde til at inhibere HIV-associerede sygdomme ved hjælp af monoklonale antistoffer rettet mod sig-selv-rettede cytotoksiske celler
US6534057B2 (en) * 1993-03-19 2003-03-18 Allen D. Allen Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
US5651970A (en) * 1993-03-19 1997-07-29 Allen; Allen D. Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics

Also Published As

Publication number Publication date
AU2003277003A1 (en) 2004-04-19
WO2004029214A8 (en) 2004-07-22
EP1545601A2 (en) 2005-06-29
WO2004029214A3 (en) 2005-02-03
EP1545601A4 (en) 2006-07-05
US6919077B2 (en) 2005-07-19
JP2006501283A (ja) 2006-01-12
CA2499924A1 (en) 2004-04-08
ZA200503173B (en) 2006-10-25
US20050142134A1 (en) 2005-06-30
CN1703240A (zh) 2005-11-30
US20040062765A1 (en) 2004-04-01
US20080038259A1 (en) 2008-02-14
WO2004029214A2 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
BR0314716A (pt) Anticorpos de subunidade alfa de lfa-1 e métodos de uso
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
CR7786A (es) Anticuerpos neutralizantes contra gdf-8 y el uso de los mismos
BR0313676A (pt) Derivados de pirimidina e uso destes como moduladores cb2
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
HN2006019066A (es) "(s)-n-metilnaltrexona"
BR0114628A (pt) Membro de retenção em microprojeção para aplicador de impacto
BRPI0501450A (pt) Composição funcional, e, artigo
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
BRPI0410031A (pt) variantes fc otimizadas e métodos para sua geração
UY29700A1 (es) "8-(3-amino-piperidin-1-il)-xantinas, su preparación y su uso como medicamentos
BRPI0411900A (pt) compostos antivirais e métodos
BRPI0411013A (pt) implante para uso na fusão de estruturas ósseas adjacentes, método de tratar um organismo para promover fusão de estruturas ósseas adjacentes e sistema para uso na fusão de estruturas ósseas adjacentes
ECSP066559A (pt)
BR9811948A (pt) Secretores de hormÈnio do crescimento
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
BR112021021645A2 (pt) Anticorpos anti-hvem e uso dos mesmos.
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
HN2002000366A (es) Anticuerpo que inhibe la actividad del factor de las celulas precursoras y su uso para el tratamiento del asma
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
TR200102742T2 (tr) Rezorsinol türevleri
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.